Cynomolgus monkeys are successfully and persistently infected with hepatitis E virus genotype 3 (HEV-3) after

Noemi Rovaris Gardinali1, Juliana Rodrigues Guimarães1, Juliana Gil Melgaço1

  • 1Laboratório de Desenvolvimento Tecnológico em Virologia, Oswaldo Cruz, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

Plos One
|March 23, 2017
PubMed

Insights

Hepatitis E virus genotype 3 (HEV-3) infection in immunosuppressed monkeys led to chronic hepatitis. Tacrolimus treatment exacerbated HEV-3 infection, causing liver damage without fibrosis, mimicking outcomes in human transplant recipients.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis E virus genotype 3 (HEV-3) infection is linked to chronic hepatitis and cirrhosis in immunocompromised individuals.
  • The role of host immunosuppressive status in the development of HEV-related chronic hepatitis requires further investigation.

Purpose of the Study:

  • To investigate the relationship between immunosuppression induced by tacrolimus and the occurrence of HEV-3 related chronic hepatitis.
  • To establish a cause-effect relationship between HEV infection and tacrolimus treatment in a primate model.

Main Methods:

  • Cynomolgus monkeys were treated with tacrolimus to induce immunosuppression and subsequently infected with a Brazilian HEV-3 strain.
  • Monkeys were monitored for 160 days, assessing clinical signs, virological, biochemical, haematological parameters, and liver histopathology.
  • Tacrolimus blood levels were monitored to confirm sustained immunosuppression.

Main Results:

  • Immunosuppression was confirmed by clinical and laboratory findings, including opportunistic infections.
  • Chronic HEV infection was characterized by persistent viremia, viral shedding, and mild liver enzyme elevation.
  • Three out of four immunosuppressed monkeys developed chronic hepatitis with significant hepatocellular damage, steatosis, and inflammation, but without fibrosis or cirrhosis.

Conclusions:

  • Tacrolimus-immunosuppressed cynomolgus monkeys infected with HEV-3 exhibited severe hepatic lesions progressing to chronic hepatitis without fibrosis.
  • These findings mimic the liver pathology observed in tacrolimus-immunosuppressed solid organ transplant recipients.
  • The study confirmed a cause-effect relationship between HEV infection and tacrolimus treatment in this experimental model.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...